Circulation Publishes 6-Month Outcomes from First-in-Human VCAS Trial of FieldForce™ Pulsed Field Ablation System: 82% Freedom from VT/VF Recurrence and 98% Reduction in Burden

Findings presented at the International VT Symposium and published simultaneously in Circulation. , /PRNewswire/ — Field Medical, Inc. today announced that Circulation has published six-month…